Who invested in Hemosphere?
Hemosphere's investors include Three Arch Partners, Kaiser Permanente Ventures, Ascension Ventures, Affinity Capital Management and Mutual Capital Partners, and 2 more on record.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$9.3Mraised across 1 round since 2010, from 1 source
Reported by onbiovc.comSEC filing: $9.3M sold, first sale Mar 2010
From Hemosphere's own website and the SEC filings it signed: 12 on the team.
On the board, as filediDavid SchulteEdson W. SpencerJonathan OsgoodMitchell W. DannTara ButlerWilliam S. Trainor
AdvisersNeil Peterson
From historical deal records. Wrong? Tell us.
Hemosphere's investors include Three Arch Partners, Kaiser Permanente Ventures, Ascension Ventures, Affinity Capital Management and Mutual Capital Partners, and 2 more on record.
Hemosphere has raised $9.3M across 1 round since 2010.
Hemosphere's most recent round was a Series A of $9.3M in Apr 2010.
Its most recent round, $9.3M in Apr 2010, is also its largest on record.
Hemosphere's first round on record, in Apr 2010, was backed by Three Arch Partners, Kaiser Permanente Ventures and Ascension Ventures and 4 others.
Hemosphere's latest named round is a Series A, in Apr 2010.
Hemosphere is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.